Eduardo Marbán, MD, PhD, is an international leader in cardiology and a pioneering heart researcher. His 30-plus years of experience in patient care and research have led to key discoveries in gene and cell therapies for heart disease. Those discoveries have formed the basis for multiple startup companies.
Currently, the Marbán Laboratory is pioneering biologically based therapies for cardiac regeneration and biological pacemakers. All lab members have a specific role in conducting their research that will, when appropriate, enable translation of discovery work from the bench to bedside. Scientific contributions are recognized by authorship on publications, as well as inventorship on patents, when appropriate. The intellectual property portfolio for CDCs and their exosomes has been licensed to a NASDAQ-listed biotech company, which continues to move these products forward in the clinical development pathway. Work on biological therapies for cardiac arrhythmias sets the pace worldwide for this area of investigation, with a view to creating novel alternatives to devices.
Meet Our Team
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Marbán Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Rogers RG, Ciullo A, Marbán E, Ibrahim AG.
Front Physiol. 2020;11:479.
Akhmerov A, Marbán E.
Circ Res. 2020 May 8;126(10):1443-1455.
Mesquita TRR, Zhang R, de Couto G, Valle J, Sanchez L, Rogers RG, Holm K, Liu W, Marbán E, Cingolani E.
Heart Rhythm. 2020 Jun;17(6):1025-1033.
de Couto G, Jaghatspanyan E, DeBerge M, Liu W, Luther K, Wang Y, Tang J, Thorp EB, Marbán E.
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2082-2096.